An economic model for the prevention of MRSA infections after surgery: Non-glycopeptide or glycopeptide antibiotic prophylaxis?

European Journal of Health Economics

Volumn 11, Issue 1, 2010, Pages 57-66

  Elliott, Rachel A ^a   Weatherly, Helen L A ^b   Hawkins, Neil S ^b   Cranny, Gillian ^c   Chambers, Duncan ^c   Myers, Lindsey ^c   Eastwood, Alison ^c   Sculpher, Mark J ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Antimicrobial prophylaxis; Economic model; Glycopeptide; Methicillin resistant Staphylococcus aureus; Surgical site infection

Indexed keywords

CEFUROXIME; ERYTHROMYCIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; HIP ARTHROPLASTY; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; STAPHYLOCOCCUS AUREUS; SURGICAL INFECTION;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ARTHROPLASTY, REPLACEMENT, HIP; CEPHALOSPORINS; CONFIDENCE INTERVALS; DECISION SUPPORT TECHNIQUES; DRUG THERAPY, COMBINATION; GLYCOPEPTIDES; GREAT BRITAIN; HUMANS; LENGTH OF STAY; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MODELS, ECONOMIC; ODDS RATIO; QUALITY-ADJUSTED LIFE YEARS; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION; VANCOMYCIN;

EID: 76649132985     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-009-0175-0     Document Type: Article

References (34)

1. National Institute for Health and Clinical Excellence (NICE): Costing statement: surgical site infection: prevention and treatment of surgical site infection. http://www.nice.org.uk/nicemedia/pdf/CG74CostStatement2.pdf (2008). Accessed 1 Mar 2009
2. R Coello A Charlett J Wilson V Ward A Pearson P Borriello 2005 Adverse impact of surgical site infections in English hospitals J Hosp Infect 60 2 93 103 10.1016/j.jhin.2004.10.019 10.1016/j.jhin.2004.10.019 (Pubitemid 40590575)
3. Scottish Intercollegiate Guidelines Network: Antibiotic prophylaxis in surgery. Scottish Intercollegiate Guidelines Network, editor. http://www.sign.ac.uk/guidelines/fulltext/45/index.html (2000). Edinburgh. Accessed 27 Jun 2007
4. Nosocomial Infection National Surveillance Service: Surveillance of surgical site infection in English hospitals 1997-2002. http://www.hpa.org.uk/ infections/topics-az/hai/SSIreport.pdf (2002). London: Public Health Laboratory Service. Accessed 27 Jun 2007
5. Gemmell, C.G., Edwards, D.I., Fraise, A.P. et al.: Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J. Antimicrob. Chemother. 57(589), 608 (2006)
6. MJ Struelens 1998 The epidemiology of antimicrobial resistance in hospital acquired infections: problems and possible solutions BMJ 317 652 654
7. Gemmell, C.G., Edwards, D.I., Fraise, A.P. et al.: Guidelines for the prophylaxis and treatment of meticillin (methicillin)-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom. http://www.bsac.org.uk/-db/- documents/MRSA-treatment-consultation.pdf Accessed 1 Mar 2005
8. S Chang DM Sievert JC Hageman ML Boulton FC Tenover FP Downes 2003 Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene N Engl J Med 348 1342 1347 10.1056/NEJMoa025025 10.1056/NEJMoa025025 (Pubitemid 36384101)
9. FC Tenover JW Biddle MV Lancaster 2001 Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus Emerg Infect Dis 7 327 332 10.3201/eid0702.010237
10. HM Aucken M Ganner S Murchan BD Cookson AP Johnson 2002 A new UK strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-17) resistant to multiple antibiotics J Antimicrob Chemother 50 171 175 10.1093/jac/dkf117 10.1093/jac/dkf117
11. X Bertrand D Hocquet M Thouverez P Plesiat D Talon 2003 Characterisation of methicillin-resistant Staphylococcus aureus with reduced susceptibility to teicoplanin in Eastern France Eur J Clin Microbiol Infect Dis 22 504 506 10.1007/s10096-003-0966-7 10.1007/s10096-003-0966-7 (Pubitemid 37100601)
12. MR Mohaved B Kasravi CS Bryan 2004 Prophylactic use of vancomycin in adult cardiology and cardiac surgery J Cardiovasc Pharmacol Ther 9 13 20 10.1177/107424840400900i103 10.1177/107424840400900i103
13. Drummond, M., Sculpher, M.J., Torrance, G., O'Brien, B.J., Stoddart, G.L.: Methods for the economic evaluation of health care programmes, 3rd edn. Oxford University Press, Oxford (2005)
14. G Cranny RA Elliott H Weatherly, et al. 2008 A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery Health Technol Assess 12 1 200
15. G Zanetti SJ Goldie R Platt 2001 Clinical consequences and cost of limiting use of vancomycin for perioperative prophylaxis: example of coronary artery bypass surgery Emerg Infect Dis 7 820 827 10.3201/eid0705.010508
16. MH Rahman J Anson 2004 Peri-operative antibacterial prophylaxis Pharm J 272 743 745
17. British Orthopaedic Association: Total hip replacement: a guide to best practice. British Orthopaedic Association, London (1999)
18. Department of Health: Bacteraemia surveillance scheme, MRSA bacteraemia by NHS Trust: table 2 data for each 6 months, 2001-2005. http://www.dh.gov.uk/ PublicationsAndStatistics/Publications/PublicationsStatistics/ PublicationsStatisticsArticle/fs/en?CONTENT-ID=4085951&chk=HBt2QD (2005). Accessed 7 Nov 2005
19. S Ridgeway J Wilson A Charlet G Kafatos A Pearson R Coello 2005 Infection of the surgical site after arthroplasty of the hip J Bone Joint Surg Br 87-B 6 844 850 10.1302/0301-620X.87B6.15121 10.1302/0301-620X.87B6.15121 (Pubitemid 40862073)
20. R Finkelstein G Rabino T Mashiah Y Bar-El Z Adler V Kertzman 2002 Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections J Thorac Cardiovasc Surg 123 326 332 10.1067/mtc.2002.119698 10.1067/mtc.2002.119698 (Pubitemid 34127121)
21. Kitzis, M., Branger, C., Andreassian, B.: Antimicrobial prophylaxis with vancomycin a comparative study in vascular surgery. Interscience Conference on Antimicrobial Agents and Chemotherapy. Program and abstracts of the Thirty-First Interscience Conference on Antimicrobial Agents and Chemotherapy, 254. (1991)
22. Niederman, M.S.: Impact of antibiotic resistance on clinical outcomes and the cost of care. Crit. Care. Med. 29 Suppl (4), N114-N120 (2001). doi: 10.1097/00003246-200104001-00011
23. TO Tengs A Wallace 2000 One thousand health-related quality-of-life estimates Med Care 38 583 637 10.1097/00005650-200006000-00004 10.1097/00005650-200006000-00004
24. National Institute for Clinical Excellence: Guide to the methods of technology appraisal. http://www.nice.org.uk/pdf/TAP-Methods.pdf (2004). Accessed 15 May 2006
25. Blom, A.W., Taylor, A.H., Pattison, G., Whitehouse, S., Bannister, G.C.: Infection after total hip arthroplasty: the Avon experience. J. Bone Joint. Surg. 85-B, 956-959 (2003)
26. T Kunori B Cookson JA Roberts S Stone C Kibbler 2002 Cost-effectiveness of different MRSA screening methods J Hosp. Infect. 51 189 200 10.1053/jhin.2002.1247 10.1053/jhin.2002.1247 (Pubitemid 38001891)
27. A Briggs R Goeree G Blackhouse BJ O'Brien 2002 Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease Med. Decis. Making 22 290 308
28. TP Lodise PS McKinnon M Rybak 2003 Prediction model to identify patients with Staphylococcus aureus bacteremia at risk for methicillin resistance Infect. Control Hosp. Epidemiol 24 655 661 10.1086/502269 10.1086/502269 (Pubitemid 37221336)
29. NHS Centre for Reviews and Dissemination: Antimicrobial prophylaxis in colorectal surgery. Eff. Health Care Bull. 4, 1-8 (1998)
30. M Brisson WJ Edmunds 2003 Economic evaluation of vaccination programs: the impact of herd-immunity Med. Decis. Making 23 76 82 10.1177/0272989X02239651 10.1177/0272989X02239651 (Pubitemid 36133362)
31. WJ Edmunds GF Medley DJ Nokes 1999 Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective Stat. Med. 18 3263 3282 10.1002/(SICI)1097-0258(19991215)18:23<3263::AID-SIM315>3.0.CO;2-3 10.1002/(SICI)1097-0258(19991215)18:23<3263::AID-SIM315>3.0.CO;2-3
32. RD Smith M Yago M Millar J Coast 2005 Assessing the macroeconomic impact of a healthcare problem: the application of computable general equilibrium analysis to antimicrobial resistance J. Health Econ. 24 1055 1075 10.1016/j.jhealeco.2005.02.003 10.1016/j.jhealeco.2005.02.003 (Pubitemid 41476212)
33. Netten, A., Dennett, J.: Unit costs of community care. ISBN 1092671406. Personal Social Services Research Unit, Kent (2005)
34. British Medical Association and Royal Pharmaceutical Society of Great Britain: British National Formulary, 50th edn. (2005)